McAlister VC, Haddad E, Renouf E et al (2006) Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. Am J Transplant 6:1578–1585. https://doi.org/10.1111/j.1600-6143.2006.01360.x

Article  CAS  PubMed  Google Scholar 

Haddad E, McAlister V, Renouf E et al (2006) Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev 2006:CD005161. https://doi.org/10.1002/14651858.CD005161.pub2

Article  PubMed  PubMed Central  Google Scholar 

Jain A, Mazariegos G, Pokharna R et al (2003) The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis1. Transplantation 75:1020–1025. https://doi.org/10.1097/01.TP.0000056168.79903.20

Article  CAS  PubMed  Google Scholar 

Venkataramanan R, Swaminathan A, Prasad T et al (1995) Clinical pharmacokinetics of tacrolimus: Clin Pharmacokinet 29:404–430. https://doi.org/10.2165/00003088-199529060-00003

Article  CAS  PubMed  Google Scholar 

Sanchez MJ, Manzanares C, Santos-Buelga D et al (2001) Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy. Clin Pharmacokinet 40:63–71. https://doi.org/10.2165/00003088-200140010-00005

Article  CAS  Google Scholar 

Ji E, Kim MG, Oh JM (2018) CYP3A5 genotype-based model to predict tacrolimus dosage in the early postoperative period after living donor liver transplantation. Ther Clin Risk Manag 14:2119–2126. https://doi.org/10.2147/TCRM.S184376

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu L, Yang J, Zhang Y et al (2015) Effects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of tacrolimus in Chinese adult liver transplant patients. Xenobiotica 45:840–846. https://doi.org/10.3109/00498254.2015.1021733

Article  CAS  PubMed  Google Scholar 

Guy-Viterbo V, Baudet H, Elens L et al (2014) Influence of donor–recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach. Pharmacogenomics 15:1207–1221. https://doi.org/10.2217/pgs.14.75

Article  CAS  PubMed  Google Scholar 

Yang J, Liao S, Zhu L et al (2015) Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation. Int J Clin Pharmacol Ther 53:75–83. https://doi.org/10.5414/CP202189

Article  CAS  PubMed  Google Scholar 

Musuamba FT, Guy-Viterbo V, Reding R et al (2014) Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation. Ther Drug Monit 36:54–61. https://doi.org/10.1097/FTD.0b013e31829dcbcd

Article  CAS  PubMed  Google Scholar 

Guy-Viterbo V, Scohy A, Verbeeck RK et al (2013) Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation. Eur J Clin Pharmacol 69:1533–1542. https://doi.org/10.1007/s00228-013-1501-0

Article  CAS  PubMed  Google Scholar 

Abdel Jalil MH, Hawwa AF, McKiernan PJ et al (2014) Population pharmacokinetic and pharmacogenetic analysis of tacrolimus in paediatric liver transplant patients. Brit J Clin Pharmacol 77:130–140. https://doi.org/10.1111/bcp.12174

Article  CAS  Google Scholar 

Fukudo M, Yano I, Masuda S et al (2006) Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients. Clin Pharmacol Ther 80:331–345. https://doi.org/10.1016/j.clpt.2006.06.008

Article  CAS  PubMed  Google Scholar 

Chen B, Shi HQ, Liu XX et al (2017) Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients. J Clin Pharm Ther 42:679–688. https://doi.org/10.1111/jcpt.12599

Article  CAS  PubMed  Google Scholar 

Fukatsu S, Yano I, Igarashi T et al (2001) Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation. Eur J Clin Pharmacol 57:479–484. https://doi.org/10.1007/s002280100331

Article  CAS  PubMed  Google Scholar 

Wallin JE, Bergstrand M, Wilczek HE et al (2011) Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance. Ther Drug Monit 33:663–672. https://doi.org/10.1097/FTD.0b013e31823415cc

Article  CAS  PubMed  Google Scholar 

Zhu L, Wang H, Sun X et al (2014) The population pharmacokinetic models of tacrolimus in Chinese adult liver transplantation patients. J Pharm (Cairo) 2014:713650. https://doi.org/10.1155/2014/713650

Article  PubMed  Google Scholar 

Kassir N, Labbé L, Delaloye J-R et al (2014) Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients: tacrolimus in paediatric liver transplant recipients. Brit J Clin Pharmacol 77:1051–1063. https://doi.org/10.1111/bcp.12276

Article  CAS  Google Scholar 

Chen X, Wang DD, Xu H, Li ZP (2020) Population pharmacokinetics and pharmacogenomics of tacrolimus in Chinese children receiving a liver transplant: initial dose recommendation. Transl Pediatr 9:576–586. https://doi.org/10.21037/tp-20-84

Article  PubMed  PubMed Central  Google Scholar 

Sam WJ, Tham LS, Holmes MJ et al (2006) Population pharmacokinetics of tacrolimus in whole blood and plasma in Asian liver transplant patients. Clin Pharmacokinet 45:59–75. https://doi.org/10.2165/00003088-200645010-00004

Article  CAS  PubMed  Google Scholar 

Zahir H, McLachlan AJ, Nelson A et al (2005) Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients. Ther Drug Monit 27:422–430. https://doi.org/10.1097/01.ftd.0000170029.36573.a0

Article  CAS  PubMed  Google Scholar 

Lu Y, Su Q, Wu K et al (2015) A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients. Acta Pharmacol Sin 36:281–288. https://doi.org/10.1038/aps.2014.110

Article  CAS  PubMed  Google Scholar 

Staatz CE, Taylor PJ, Lynch SV et al (2001) Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants. Transplantation 72:1056–1061. https://doi.org/10.1097/00007890-200109270-00013

Article  CAS  PubMed  Google Scholar 

Li D, Lu W, Zhu J-Y et al (2007) Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients: tacrolimus population pharmacokinetics and CYP3A5. J Clin Pharm Ther 32:505–515. https://doi.org/10.1111/j.1365-2710.2007.00850.x

Article  CAS  PubMed  Google Scholar 

Sam WJ, Aw M, Quak SH et al (2000) Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients. Brit J Clin Pharmacol 50:531–541. https://doi.org/10.1046/j.1365-2125.2000.00288.x

Article  CAS  Google Scholar 

Khamlek K, Komenkul V, Sriboonruang T, Wattanavijitkul T (2024) Population pharmacokinetic models of tacrolimus in paediatric solid organ transplant recipients: a systematic review. Brit J Clin Pharmacol 90:406–426. https://doi.org/10.1111/bcp.15909

Article  CAS  Google Scholar 

Shao J, Wang C, Fu P et al (2020) Impact of donor and recipient CYP3A5*3 genotype on tacrolimus population pharmacokinetics in Chinese adult liver transplant recipients. Ann Pharmacother 54:652–661. https://doi.org/10.1177/1060028019897050

Article  CAS  PubMed  Google Scholar 

Moes DJAR, Van Der Bent SAS, Swen JJ et al (2016) Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients. Eur J Clin Pharmacol 72:163–174. https://doi.org/10.1007/s00228-015-1963-3

Article  CAS